Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
SAB Biotherapeutics, Inc.SAB Biotherapeutics Reports $10.1 Million Net Loss in Q2 2025, Seeks Funding for Clinical Trials
Verano Holdings Corp.Verano Holdings Reports Q2 2025 Financial Results with $202.3M Revenue and Net Loss of $19.2M
Amylyx Pharmaceuticals, Inc.Amylyx Pharmaceuticals Reports $41.4 Million Net Loss in Q2 2025, Focuses on Clinical Pipeline
C4 Therapeutics, Inc.C4 Therapeutics Reports $26M Net Loss in Q2 2025, Revenue Declines
Phathom Pharmaceuticals, Inc.Phathom Pharmaceuticals Reports $39.5M Product Revenue in Q2 2025, Faces $75.8M Net Loss
KALTURA INCKaltura Reports Q2 2025 Financial Results with $44.5M Revenue and Improved Net Loss
Cartesian Therapeutics, Inc.Cartesian Therapeutics Reports Q2 2025 Revenue Decline to $298,000 Amid Increased Operating Expenses
Monte Rosa Therapeutics, Inc.Monte Rosa Therapeutics Reports $23.2M Collaboration Revenue and $12.3M Net Loss for Q2 2025
Liberty Latin America Ltd.Liberty Latin America Reports Revenue Decline and Significant Operating Loss in Q2 2025
Cullinan Therapeutics, Inc.Cullinan Therapeutics Reports $70.1 Million Net Loss in Q2 2025
1stdibs.com, Inc.1stdibs.com Reports Slight Decline in Q2 2025 Net Revenue, Net Loss of $4.3 Million
DraftKings Inc.DraftKings Reports 36.9% Revenue Growth to $1.51 Billion in Q2 2025
Black Diamond Therapeutics, Inc.Black Diamond Therapeutics Reports $45.98 Million Net Income and Advances Silevertinib in Latest 10-Q
Avalo Therapeutics, Inc.Avalo Therapeutics Reports $33.9 Million Net Loss and Increased R&D Expenses for First Half of 2025
PAPA JOHNS INTERNATIONAL INCPapa John’s Reports 4.2% Revenue Growth in Q2 2025, Faces Decline in Net Income
Immunocore Holdings plcImmunocore Reports 30% Revenue Growth to $97.964 Million in Q2 2025
Chicago Atlantic Real Estate Finance, Inc.Chicago Atlantic Real Estate Finance Reports Q2 2025 Financial Results with $8.9M Net Income
INSMED IncInsmed Reports 18.9% Revenue Growth to $107.4 Million in Q2 2025
STARWOOD PROPERTY TRUST, INC.Starwood Property Trust Reports Q2 2025 Financial Results with Revenue Decline and Increased Net Income
IMMUNIC, INC.Immunic Reports $26.8 Million Net Loss in Q2 2025, Increases Operating Expenses
Arhaus, Inc.Arhaus Reports 10.7% Revenue Growth to $669.8 Million for First Half of 2025
Nuvalent, Inc.Nuvalent Reports $99.7 Million Net Loss in Q2 2025 Amid Increased R&D Spending
Hut 8 Corp.Hut 8 Corp. Reports 17.3% Revenue Growth and $137.3 Million Net Income in Q2 2025
Aveanna Healthcare Holdings, Inc.Aveanna Healthcare Reports 16.8% Revenue Growth to $589.6 Million in Q2 2025
Idaho Strategic Resources, Inc.Idaho Strategic Resources Reports 54.7% Revenue Growth in Q2 2025